Amy Brown
Family · Frenchburg, KYNPI 1558818401
Payments from drug & device makers
Across 164 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$601
- Amgen$441
- AbbVie$369
- Johnson & Johnson$230
- Novartis$181
- Indivior Inc.$135
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,99499%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 31 | $601 |
| Amgen | 21 | $441 |
| AbbVie | 21 | $369 |
| Johnson & Johnson | 15 | $230 |
| Novartis | 9 | $181 |
| Indivior Inc. | 7 | $135 |
| Boehringer Ingelheim | 9 | $126 |
| Bayer | 7 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $118 |
| AstraZeneca(2 entities) | 7 | $106 |
| Xeris Pharmaceuticals, Inc. | 4 | $83 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $73 |
| Novo Nordisk | 4 | $69 |
| Exact Sciences | 3 | $55 |
| Abbott | 2 | $40 |
| Lilly USA, LLC | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Boston Scientific | 1 | $28 |
| Braeburn Inc. | 2 | $27 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Smith+Nephew | 1 | $20 |
| Pfizer | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
How this compares
$3,014 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 78 | $66,006 |
| OzempicSemaglutide | 48 | $54,625 |
| JardianceEmpagliflozin | 31 | $35,435 |
| FarxigaDapagliflozin Propanediol | 21 | $20,381 |
| XareltoRivaroxaban | 14 | $17,053 |
| JanuviaSitagliptin Phosphate | 12 | $11,156 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $4,629 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 24 | $2,990 |
| Insulin Aspart Prot Mix 70-30Insulin Aspart Prot/Insuln Asp | 11 | $2,740 |
| Insulin Lispro Protamine MixInsulin Lispro Protamin/Lispro | 13 | $2,029 |
| Duloxetine Hcl | 114 | $2,008 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 50 | $1,478 |
| Omeprazole | 236 | $1,178 |
| Levothyroxine Sodium | 127 | $1,005 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 14 | $823 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $601 | $66,00678 claims |
| Novo NordiskOzempic | $69 | $54,62548 claims |
| Boehringer IngelheimJardiance | $126 | $35,43531 claims |
| AstraZenecaFarxiga | $106 | $20,38121 claims |
| Johnson & JohnsonXarelto | $230 | $17,05314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.
Other family in Frenchburg
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.